EIF4E inhibitors and uses thereof
US12030875B2 · kind B2 · utility
0Cited by
17References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 6, 2019 |
| Grant date | Jul 9, 2024 |
| Priority date | — |
| Expiry date | Dec 9, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds inhibiting eIF4E activity, and compositions and methods of using thereof. Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful for treating a variety of diseases, disorders or conditions, associated with eIF4E. Such diseases, disorders, or conditions include cellular proliferative disorders (e.g., cancer) such as those described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.